News

Researchers from IDIBELL and the UB identify 15 new cell populations in the pancreas.
Led by Dr. Meritxell Rovira thanks to the CRIS Program of Excellence 2023, this new study will provide a better understanding of how pancreatic cancer develops.

The cause is a change in the epigenetic pattern of the beta cells of the pancreas, which overexpress oncogenes and genes related to insulin production, thus altering their functioning. This change in pattern, a common factor in the vast majority of tumours, is due to the accumulation of different mutations in genes involved in the regulation of gene expression.

M. Carolina Florian and Alessandra Giorgetti, group leaders of the Regenerative Medicine Program at IDIBELL, are part of the organizing committee.
The congress featured more than ten national and international speakers, and 135 participants.

The ICREA Research Professor at P-CRM[C] recently demonstrated how to “hack” the immune system to slow down aging.

The scientist from P-CRM[C], IDIBELL and the University of Barcelona will lead a project aimed at identifying new early detection markers and developing personalized medicine strategies for this pathology.
The recognition granted by the CRIS Foundation against cancer aims to promote and consolidate the careers of researchers with an endowment of up to 1,250,000 euros.
In this call, grants totaling 11.4 million euros have been awarded to ensure that advances in research have a broader reach and impact the treatments received by patients.

Scientists led by Dr Anna Veiga and Dr Sergi Querol have generated seven pluripotent stem cell lines from umbilical cord blood, compatible with 20% of the Spanish population.

These induced pluripotent stem cells (iPSCs) are created from adult cells from umbilical cord blood and can be used to produce advanced therapy drugs and test them in clinical trials, for example in retinal regeneration, heart, or immunotherapies.

Certain variations in our DNA, which had previously gone unnoticed, can have a significant impact on the development of cancer.
62% of the cancer susceptibility genes identified are completely new, which opens up new avenues of study in cancer research.

Astrocytes in the brains of Parkinson’s patients overexpress the inflammatory cytokine IL-6, which induces the death of dopaminergic neurons.
The results have been obtained thanks to obtaining induced pluripotent stem cells from Parkinson’s patients.

Stem Cell Potency group, lead by Dr. Ángel Raya at the P-CMR[C] and IDIBELL, together with three other research teams from IDIBELL, have been awarded by La Marató 3Cat Foundation.

We are pleased to announce the First RegenBell symposium on Stem Cells and Regenerative Medicine, which will take place on November 27-28th at the Institut d’Estudis Catalans, downtown in Barcelona. The primary goal of the symposium is to establish an inclusive and collaborative platform for scientists interested in Regenerative Medicine.